Toxicity of secondary metabolites

References

[1] Williams DH, Stone MJ, Hauck PR, Rahman SK. Why are secondary metabolites (natural products) biosynthesized? J Nat Prod. 1989;52:1189–208.10.1021/np50066a001Search in Google Scholar PubMed

[2] Croteau R, Kutchan T, Lewis NG. Natural products (secondary metabolites). In: Buchanan B, Gruissem W, Jones R, editors. Biochemistry & molecular biology of plants. American Society of Plant Physiologists, 2000:1250–319.Search in Google Scholar

[3] Schoental R. Toxicology of natural products. Food Cosmet Toxicol. 1965;3:609–20.10.1016/S0015-6264(65)80209-7Search in Google Scholar

[4] Petrovska B. Historical review of medicinal plants usage. Pharmacogn Rev. 2012;6:1–5.10.4103/0973-7847.95849Search in Google Scholar PubMed PubMed Central

[5] Kirk JL, Beaudette LA, Hart M, Moutoglis P, Klironomos JN, Lee H, et al. Methods of studying soil microbial diversity. J Microbiol Methods. 2004;58:169–88.10.1016/j.mimet.2004.04.006Search in Google Scholar PubMed

[6] Debbab A, Aly AH, Proksch P. Bioactive secondary metabolites from endophytes and associated marine derived fungi. Fungal Divers. 2011;49:1–12.10.1007/s13225-011-0114-0Search in Google Scholar

[7] Zuo H, Zhang Q, Su S, Chen Q, Yang F, Hu Y. A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: an example of Yu Ping Feng decoction. Sci Rep. 2018;8:1–15.10.1038/s41598-018-29764-1Search in Google Scholar PubMed PubMed Central

[8] Saldívar-González FI, Pilón-Jiménez BA, Medina-Franco JL. Chemical space of naturally occurring compounds. Phys Sci Rev. 2018. DOI: 10.1515/psr-2018-0103.Search in Google Scholar

[9] Pal S. A journey across the sequential development of macrolides and ketolides related to erythromycin. Tetrahedron. 2006;62:3171–200.10.1016/j.tet.2005.11.064Search in Google Scholar

[10] Leong YH, Latiff AA, Ahmad NI, Rosma A. Exposure measurement of aflatoxins and aflatoxin metabolites in human body fluids. A short review. Mycotoxin Res. 2012;28:79–87.10.1007/s12550-012-0129-8Search in Google Scholar PubMed

[11] Kumar P, Mahato DK, Kamle M, Mohanta TK, Kang SG. Aflatoxins: a global concern for food safety, human health and their management. Front Microbiol. 2017;7:2170.10.3389/fmicb.2016.02170Search in Google Scholar PubMed PubMed Central

[12] Lachenmeier DW, Walch SG, Padosch SA, Kröner LU. Absinthe—a review. Crit Rev Food Sci Nutr. 2006;46:365–77.10.1080/10408690590957322Search in Google Scholar PubMed

[13] Edris AE. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phyther Res. 2007;21:308–23.10.1002/ptr.2072Search in Google Scholar PubMed

[14] Altmann KH, Gertsch J. Anticancer drugs from nature – natural products as a unique source of new microtubule-stabilizing agents. Nat Prod Rep. 2007;24:327–57.10.1039/B515619JSearch in Google Scholar PubMed

[15] Kingston DGI. The shape of things to come: structural and synthetic studies of taxol and related compounds. Phytochemistry. 2007;68:1844–54.10.1016/j.phytochem.2006.11.009Search in Google Scholar PubMed PubMed Central

[16] Gobbini M, Cerri A. Digitalis-like compounds: the discovery of the O-aminoalkyloxime group as a very powerful substitute for the unsaturated [gamma]-butyrolactone moiety. Curr Med Chem. 2005;12:2343–55.10.2174/0929867054864787Search in Google Scholar PubMed

[17] Mooibroek H, Cornish K. Alternative sources of natural rubber. Appl Microbiol Biotechnol. 2000;53:355–65.10.1007/s002530051627Search in Google Scholar PubMed

[18] Piraee M, Magarvey N, He J, Vining LC. The gene cluster for chloramphenicol biosynthesis in Streptomyces venezuelae ISP5230 includes novel shikimate pathway homologues and a monomodular non-ribosomal peptide synthetase gene. Microbiology. 2001;147:2817–29.10.1099/00221287-147-10-2817Search in Google Scholar PubMed

[19] Razzaghi-Asl N, Garrido J, Khazraei H, Borges F, Firuzi O. Antioxidant properties of hydroxycinnamic acids: a review of structure- activity relationships. Curr Med Chem. 2013;20:4436–50.10.2174/09298673113209990141Search in Google Scholar PubMed

[20] Shareef MA, Duscharla D, Ramasatyaveni G, Dhoke NR, Das A, Ummanni R, et al. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Eur J Med Chem. 2015;89:128–37.10.1016/j.ejmech.2014.10.050Search in Google Scholar PubMed

[21] Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem. 2005;12:887–916.10.2174/0929867053507315Search in Google Scholar PubMed

[22] Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, Panopoulos N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: chemical diversity, impacts on plant biology and human health. Biotechnol J. 2007;2:1214–34.10.1002/biot.200700084Search in Google Scholar PubMed

[23] Gambini J, Inglés M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L, et al. Properties of resveratrol: in Vitro and In Vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015;2015:837042.10.1155/2015/837042Search in Google Scholar PubMed PubMed Central

[24] Madariaga-Mazón A, Marmolejo-Valencia AF, Li Y, Toll L, Houghten RA, Martinez-Mayorga K. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics? Drug Discov Today. 2017;22:1719–29.10.1016/j.drudis.2017.07.002Search in Google Scholar PubMed PubMed Central

[25] Ashihara H, Sano H, Crozier A. Caffeine and related purine alkaloids: biosynthesis, catabolism, function and genetic engineering. Phytochemistry. 2008;69:841–56.10.1016/j.phytochem.2007.10.029Search in Google Scholar PubMed

[26] Wexler P, Fonger GC, White J, Weinstein S. Toxinology: taxonomy, interpretation, and information resources. Sci Technol Libr. 2015;34:67–90.10.1080/0194262X.2014.993788Search in Google Scholar

[27] Fox J, Serrano S. Approaching the golden age of natural product pharmaceuticals from venom libraries: an overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications. Curr Pharm Des. 2007;13:2927–34.10.2174/138161207782023739Search in Google Scholar PubMed

[28] Environmental Health & Safety. University of Florida. http://www.ehs.ufl.edu/.Search in Google Scholar

[29] Lewis RJ. Sax’s dangerous properties of industrial materials. J Am Chem Soc. 2005;127:2794–4.10.1002/0471701343Search in Google Scholar

[30] Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47:D1102–9.10.1093/nar/gky1033Search in Google Scholar PubMed PubMed Central

[31] Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074–82.10.1093/nar/gkx1037Search in Google Scholar PubMed PubMed Central

[32] Budavari S. The merck index : an encyclopedia of chemicals, drugs, and biologicals, 11th ed. (Budavari S, ed.). N.J., USA: Rahway, 1989.Search in Google Scholar

[33] Sine C. Nicotine. In: Meister RT, editor. Farm chemicals handbook ’93. Willoughby, Ohio: 1993:C245Search in Google Scholar

[34] Patocka J, Pita R, Kuca K. Gyromitrin, mushroom toxin of gyromitra spp. Mil Med Sci Lett. 2012;81:61–7.10.31482/mmsl.2012.008Search in Google Scholar

[35] Adewusi SR, Oke OL. On the metabolism of amygdalin. 1. The LD50 and biochemical changes in rats. Can J Physiol Pharmacol. 1985;63:1080–3.10.1139/y85-177Search in Google Scholar PubMed

[36] Parasuraman S. Toxicological screening. J Pharmacol Pharmacother. 2011;2:74–9.10.4103/0976-500X.81895Search in Google Scholar PubMed PubMed Central

[37] OECD. Test No. 452: chronic toxicity studies. OECD, 2009. DOI: 10.1787/9789264071209-en.Search in Google Scholar

[38] Ruiz P, Yang X, Lumen A, Fisher J. Quantitative structure-activity relationship (QSAR) models, physiologically based pharmacokinetic (PBPK) models, biologically based dose response (BBDR) and toxicity pathways: computational tools for public health. In: Comput Toxicol. January 2013:5–21.10.1016/B978-0-12-396461-8.00002-6Search in Google Scholar

[39] Ruiz P, Fowler BA, Osterloh JD, Fisher J, Mumtaz M. Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants – metals. SAR QSAR Environ Res. 2010;21:603–18.10.1080/1062936X.2010.528942Search in Google Scholar PubMed

[40] Ruiz P, Mumtaz M, Osterloh J, Fisher J, Fowler BA. Interpreting NHANES biomonitoring data, cadmium. Toxicol Lett. 2010;198:44–8.10.1016/j.toxlet.2010.04.022Search in Google Scholar PubMed

[41] Mumtaz MM, Ray M, Crowell SR, Keys D, Fisher J, Ruiz P. Translational research to develop a human PBPK models tool kit—volatile organic compounds (VOCs). J Toxicol Environ Heal Part A. 2012;75:6–24.10.1080/15287394.2012.625546Search in Google Scholar PubMed PubMed Central

[42] Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N. Minireview physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verifications. DRUG Metab Dispos Drug Metab Dispos. 2015;43:1823–37.10.1124/dmd.115.065920Search in Google Scholar PubMed PubMed Central

[43] Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, et al. Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol. 2017;91:3477–505.10.1007/s00204-017-2045-3Search in Google Scholar PubMed

[44] Kerns EH, Di L, Kerns EH, Di L. Toxicity. Drug-like prop concepts, struct design and methods from ADME to toxicity optimization. Elsevier, 2008:215–23.10.1016/B978-012369520-8.50018-8Search in Google Scholar

[45] Segall MD, Barber C. Addressing toxicity risk when designing and selecting compounds in early drug discovery. Drug Discov Today. 2014;19:688–93.10.1016/j.drudis.2014.01.006Search in Google Scholar PubMed

[46] Lewis KA, Tzilivakis J, Warner DJ, Green A. An international database for pesticide risk assessments and management. Hum Ecol Risk Assess An Int J. 2016;22:1050–64.10.1080/10807039.2015.1133242Search in Google Scholar

[47] Duke SO, Cantrell CL, Meepagala KM, Wedge DE, Tabanca N, Schrader KK. Natural toxins for use in pest management. Toxins (Basel). 2010;2:1943–62.10.3390/toxins2081943Search in Google Scholar PubMed PubMed Central

[48] Madariaga-Mazón A, Osnaya-Hernández A, Chávez-Gómez A, García-Ramos JC, Cortés-Guzmán F, Castillo-Pazos DJ, et al. Distribution of toxicity values across different species and modes of action of pesticides from PESTIMEP and PPDB databases. Toxicol Res. 2019;8:146–56.10.1039/C8TX00322JSearch in Google Scholar PubMed PubMed Central

[49] Duke SO, Rimando AM, Schrader KK, Cantrell CL, Meepagala KM, Wedge DE, et al. Natural products for pest management. In: Ikan R, editor. Selected topics in the chemistry of natural products. World Scientific, 2008:209–51.10.1142/9789812790781_0008Search in Google Scholar

[50] Duke SO, Dayan FE. Modes of action of microbially-produced phytotoxins. Toxins. 2011;3:1038–64.10.3390/toxins3081038Search in Google Scholar PubMed PubMed Central

[51] Owens DK, Nanayakkara NPD, Dayan FE. In planta mechanism of action of leptospermone: impact of its physico-chemical properties on uptake, translocation, and metabolism. J Chem Ecol. 2013;39:262–70.10.1007/s10886-013-0237-8Search in Google Scholar PubMed

[52] Williams T, Valle J, Viñuela E. Is the naturally derived insecticide Spinosad® compatible with insect natural enemies? Biocontrol Sci Technol. 2003;13:459–75.10.1080/0958315031000140956Search in Google Scholar

[53] Putter I, Mac Connell JG, Preiser FA, Haidri AA, Ristich SS, Dybas RA. Avermectins: novel insecticides, acaricides and nematicides from a soil microorganism. Experientia. 1981;37:963–4.10.1007/BF01971780Search in Google Scholar

[54] Gupta RC. Rotenone. In: Wexler P, editor. Encyclopedia of toxicology. Elsevier, 2014:185–7.10.1016/B978-0-12-386454-3.00194-9Search in Google Scholar

[55] Prabhakaran G, Bhore S, Ravichandran M. Development and evaluation of poly herbal molluscicidal extracts for control of apple snail (Pomacea maculata). Agriculture. 2017;7:22.10.3390/agriculture7030022Search in Google Scholar

[56] Kariuki ST, Kariuki JM, Mailu BM, Muchiri DR. Phytolacca octandra (L.), Phytolacca dodecandra (L’Herit) and Balanites aegypiaca (L.) extracts as potential molluscicides of schistosomiasis transmitting snails. J Med Plants Res. 2017;10:823–8.10.5897/JMPR2016.6237Search in Google Scholar

[57] Schrader KK, De Regt MQ, Tidwell PR, Tucker CS, Duke SO. Selective growth inhibition of the musty-odor producing Cyanobacterium Oscillatoria cf. chalybea by natural compounds. Bull Environ Contam Toxicol. 1998;60:651–8.10.1007/s001289900676Search in Google Scholar PubMed

[58] O’Neil J, Scarrott B, Svalheim RA, Elliott J, Hodges SJ. Vitamin K2 in animal health: an overview. In: Gordeladze J, editor. Vitamin K2 – vital for health and wellbeing. InTech, 2017:215–36.Search in Google Scholar

[59] Liang S, Xu X, Lu Z. Effect of azoxystrobin fungicide on the physiological and biochemical indices and ginsenoside contents of ginseng leaves. J Ginseng Res. 2018;42:175–82.10.1016/j.jgr.2017.02.004Search in Google Scholar PubMed PubMed Central

[60] Xie Y, Huang Q, Wang Z, Cao H, Zhang D. Structure-activity relationships of cinnamaldehyde and eugenol derivatives against plant pathogenic fungi. Ind Crops Prod. 2017;97:388–94.10.1016/j.indcrop.2016.12.043Search in Google Scholar

[61] Cantrell CL, Case BP, Mena EE, Kniffin TM, Duke SO, Wedge DE. Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus. J Agric Food Chem. 2008;56:5062–8.10.1021/jf8008662Search in Google Scholar PubMed